Shockwave Medical Inc

2
NAS:SWAV (USA)  
$ 328.87 0 (0%) 04:00 PM EST
84.98
P/B:
18.19
Market Cap:
$ 12.34B
Enterprise V:
$ 12.12B
Volume:
163.00
Avg Vol (2M):
1.32M
Also Trade In:
Volume:
163.00
Avg Vol (2M):
1.32M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for SWAV ( Shockwave Medical Inc ) from 2019 to Apr 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shockwave Medical stock (SWAV) PE ratio as of Apr 25 2024 is 84.98. More Details

Shockwave Medical Inc (SWAV) PE Ratio (TTM) Chart

To

Shockwave Medical Inc (SWAV) PE Ratio (TTM) Historical Data

Total 1215
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Shockwave Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-25 85.0 2024-02-21 66.8
2024-04-24 85.0 2024-02-20 67.0
2024-04-23 84.9 2024-02-16 67.9
2024-04-22 84.9 2024-02-15 61.1
2024-04-19 85.0 2024-02-14 59.7
2024-04-18 84.6 2024-02-13 59.9
2024-04-17 84.6 2024-02-12 60.9
2024-04-16 84.6 2024-02-09 60.4
2024-04-15 84.5 2024-02-08 61.2
2024-04-12 84.7 2024-02-07 61.1
2024-04-11 84.8 2024-02-06 61.2
2024-04-10 85.2 2024-02-05 59.7
2024-04-09 84.6 2024-02-02 60.3
2024-04-08 84.1 2024-02-01 59.9
2024-04-05 84.3 2024-01-31 58.5
2024-04-04 82.7 2024-01-30 58.5
2024-04-03 82.9 2024-01-29 58.9
2024-04-02 82.7 2024-01-26 58.7
2024-04-01 82.8 2024-01-25 58.0
2024-03-28 84.1 2024-01-24 58.0
2024-03-27 83.4 2024-01-23 57.7
2024-03-26 81.7 2024-01-22 56.2
2024-03-25 74.2 2024-01-19 56.1
2024-03-22 72.6 2024-01-18 57.1
2024-03-21 73.7 2024-01-17 56.5
2024-03-20 73.8 2024-01-16 56.1
2024-03-19 72.2 2024-01-12 55.9
2024-03-18 71.6 2024-01-11 55.4
2024-03-15 70.8 2024-01-10 56.6
2024-03-14 68.8 2024-01-09 52.5
2024-03-13 69.6 2024-01-08 53.2
2024-03-12 68.4 2024-01-05 51.7
2024-03-11 66.6 2024-01-04 50.8
2024-03-08 65.0 2024-01-03 49.4
2024-03-07 66.2 2024-01-02 50.3
2024-03-06 65.8 2023-12-29 49.2
2024-03-05 65.1 2023-12-28 49.4
2024-03-04 67.3 2023-12-27 29.8
2024-03-01 68.1 2023-12-26 30.1
2024-02-29 67.4 2023-12-22 29.9
2024-02-28 67.8 2023-12-21 29.8
2024-02-27 68.1 2023-12-20 29.3
2024-02-26 67.2 2023-12-19 29.9
2024-02-23 67.4 2023-12-18 29.3
2024-02-22 69.9 2023-12-15 29.2

Shockwave Medical Inc (SWAV) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Shockwave Medical Inc is a medical device company focused on developing and commercializing novel technologies that transform the care of patients with cardiovascular disease. It establishes a new standard of care for the treatment of calcified cardiovascular disease ("atherosclerosis") through differentiated and proprietary local delivery of sonic pressure waves, which refer to as intravascular lithotripsy ("IVL"). Its IVL technology is a minimally invasive, easy-to-use, and safe way to improve outcomes for patients with calcified cardiovascular disease also IVL catheters enables delivery of IVL therapy to diseased vasculature throughout the body for calcium modification.